Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
Adverum Biotechnologies Free Cash Flow: -138.44M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Pfizer Inc. | 10.38B |
| Recursion Pharmaceuticals, Inc. | -450.20M |
| Quantum-Si, Inc. | -105.22M |
| X4 Pharmaceuticals, Inc. | -106.13M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.12M |
| Cash from Investing (Quarterly) | 1.858M |
| Cash from Financing (Quarterly) | 9.899M |
| Free Cash Flow Per Share (Quarterly) | -1.203 |
| Free Cash Flow to Equity (Quarterly) | -24.98M |
| Free Cash Flow to Firm (Quarterly) | -28.26M |
| Free Cash Flow Yield | -147.1% |